# Hepatoprotective Effect of Cynarin on Alpha-Naphthyl Isothiocyanate-Induced Cholestatic Liver Injury: Associated Modulation of TXNIP/NLRP3 and HMGB1/NF-κB Signaling Cascades

**Authors:** Hani M. Alrawili, Mahmoud Elshal, Marwa S. Serrya, Dina S. El-Agamy

PMC · DOI: 10.3390/ph19020280 · 2026-02-07

## TL;DR

Cynarin, a plant compound, protects the liver from injury caused by a toxic chemical by reducing inflammation and oxidative stress.

## Contribution

This study reveals the novel protective mechanism of cynarin against cholestatic liver injury via modulating specific inflammatory pathways.

## Key findings

- Cynarin reduced liver damage and restored redox balance in mice with cholestatic injury.
- Cynarin suppressed key inflammatory markers like TXNIP, NLRP3, and HMGB1/NF-κB pathways.
- Cynarin decreased pro-inflammatory cytokines such as IL-1β and IL-18 in hepatic tissue.

## Abstract

Background: Cholestatic liver injury (CLI) is characterized by complex pathogenesis; however, oxidative stress-mediated inflammatory response due to bile acid accumulation in the liver is considered a primary cause. Cynarin (CN), an artichoke phytochemical, has demonstrated different biological activities, including antioxidant and anti-inflammatory ones. The current study aimed to explore the potential hepatoprotective effect of CN on CLI induced by alpha-naphthyl isothiocyanate (ANIT) in mice and investigate the possible involved mechanisms. Methods: Mice received CN (25 and 50 mg/kg) for four consecutive days and were challenged with ANIT (75 mg/kg) once on the second day. Liver injury was examined through biochemical determination of liver injury biomarkers and confirmed by histopathological evaluation. Oxidative stress biomarkers and pro-inflammatory cytokines were detected in the hepatic tissue. RT-PCR, Western blotting, and ELISA were applied to address gene and protein expression of potential underlying molecular targets, including thioredoxin-interacting protein (TXNIP), NLR family pyrin domain-containing 3 (NLRP3) inflammasome, and high-mobility group box 1 (HMGB1). Moreover, nuclear factor kappa-B (NF-κB) activation was determined by immunohistochemical analysis. Results: Our findings revealed that CN remarkably ameliorated ANIT-induced hepatic necro-inflammatory changes and biliary duct injury and restored redox balance in the liver. Mechanistically, CN markedly decreased the expression of TXNIP, NLRP3, active caspase-1, gasdermin D N-terminal (GSDMD-N), interleukin (IL)-1β, and IL-18, which were elevated upon ANIT administration. Moreover, CN suppressed ANIT-induced expression of HMGB1 and NF-κB. Conclusions: Our findings suggest that CN has a protective effect against ANIT-induced CLI in mice that is associated with modulation of the TXNIP/NLRP3 and HMGB1/NF-κB signaling cascades.

## Linked entities

- **Genes:** TXNIP (thioredoxin interacting protein) [NCBI Gene 10628], NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548], GSDMD (gasdermin D) [NCBI Gene 79792], IL1B (interleukin 1 beta) [NCBI Gene 3553], IL18 (interleukin 18) [NCBI Gene 3606], HMGB1 (high mobility group box 1) [NCBI Gene 3146], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790]
- **Proteins:** TXNIP (thioredoxin interacting protein), NLRP3 (NLR family pyrin domain containing 3), HMGB1 (high mobility group box 1), NFKB1 (nuclear factor kappa B subunit 1)
- **Chemicals:** Cynarin (PubChem CID 5281769), alpha-naphthyl isothiocyanate (PubChem CID 11080)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Txnip (thioredoxin interacting protein) [NCBI Gene 56338] {aka 1200008J08Rik, Hyplip1, THIF, Tbp-2, VDUP1}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, CASP1 (caspase 1) [NCBI Gene 834] {aka ICE, IL1BC, P45}, Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Gpt (glutamic pyruvic transaminase, soluble) [NCBI Gene 76282] {aka 1300007J06Rik, 2310022B03Rik, ALT, ALT1, Gpt-1, Gpt1}, HMGB1 (high mobility group box 1) [NCBI Gene 3146] {aka HMG-1, HMG1, HMG3, SBP-1}, Slc17a5 (solute carrier family 17 (anion/sugar transporter), member 5) [NCBI Gene 235504] {aka 4631416G20Rik, 4732491M05, AST, ISSD, NSD, SD}, Casp1 (caspase 1) [NCBI Gene 12362] {aka ICE, Il1bc}, Hmgb1 (high mobility group box 1) [NCBI Gene 15289] {aka HMG-1, Hmg1, SBP-1, p30}, Txn1 (thioredoxin 1) [NCBI Gene 22166] {aka ADF, Trx1, Txn}, Nfe2l2 (nuclear factor, erythroid derived 2, like 2) [NCBI Gene 18024] {aka Nrf2}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, ATHS (atherosclerosis susceptibility (lipoprotein associated)) [NCBI Gene 470] {aka ALP}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Pdlim3 (PDZ and LIM domain 3) [NCBI Gene 114108] {aka Actn2lp, Alp}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, TXNIP (thioredoxin interacting protein) [NCBI Gene 10628] {aka ARRDC6, EST01027, HHCPA78, THIF, VDUP1}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, alp (alopecia, recessive) [NCBI Gene 11691], Pycard (PYD and CARD domain containing) [NCBI Gene 66824] {aka 9130417A21Rik, Asc, CARD5, TMS-1, TNS1, masc}, Il18 (interleukin 18) [NCBI Gene 16173] {aka Igif, Il-18}, Gsdmd (gasdermin D) [NCBI Gene 69146] {aka 1810036L03Rik, DF5L, Dfna5l, GsdmD-1, Gsdmdc1, M2-4}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}
- **Diseases:** carcinogenic (MESH:D011230), centrilobular necrosis (MESH:D011656), atherosclerotic (MESH:D050197), cholestasis (MESH:D002779), toxicity (MESH:D064420), cholestatic liver damage (MESH:D056486), CLI (MESH:D017093), dislocation (MESH:D004204), necrosis (MESH:D009336), duct blockage (MESH:D015508), hepatocyte injury (MESH:D014947), hepatic pathogenic disorder (MESH:D008107), hepatic inflammation (MESH:D007249), biliary fibrosis (MESH:D005355), Intrahepatic cholestasis (MESH:D002780), gout arthritis (MESH:D006073), mitochondrial dysfunction (MESH:D028361), biliary duct injury (MESH:D042882), bile tract tumors (MESH:D009369), ANIT (MESH:D000795), swelling (MESH:D004487), nausea (MESH:D009325), jaundice (MESH:D007565), extrahepatic cholestasis (MESH:D001651), itching (MESH:D011537), bile duct damage (MESH:D001649)
- **Chemicals:** CN25 (-), ANIT (MESH:D015058), bile acid (MESH:D001647), H&amp;E (MESH:D006371), hematoxylin (MESH:D006416), corn oil (MESH:D003314), MDA (MESH:D008315), GSH (MESH:D005978), lipid (MESH:D008055), eosin (MESH:D004801), CN (MESH:C100257), PBS (MESH:D007854), PVDF (MESH:C024865), formalin (MESH:D005557), ROS (MESH:D017382), paraffin (MESH:D010232), methanol (MESH:D000432), thiopental sodium (MESH:D013874), phosphate (MESH:D010710), 1,3-Dicaffeoylquinic acid (MESH:C487840), TBIL (MESH:D001663), CCL4 (MESH:D002251), polyacrylamide (MESH:C016679), cholesterol (MESH:D002784), glycine (MESH:D005998)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Human immunodeficiency virus 1 (no rank) [taxon 11676]

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12943477/full.md

---
Source: https://tomesphere.com/paper/PMC12943477